21.   Even if the panel votes Friday to back FluMist, and if the FDA ultimately approves the vaccine, it would not be for everyone.

22.   If the panel backs FluMist, and if the FDA ultimately approves the vaccine, it will not be for everyone.

23.   The Food and Drug Administration approved the vaccine, called Havrix, on Wednesday.